Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3077)
All Articles published online
|
Apr 14, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zuberi BF, Zuberi FF, Memon SA, Qureshi MH, Ali SZ, Afsar S. Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population. World J Gastroenterol 2008; 14(14): 2218-2221 [PMID: 18407597 DOI: 10.3748/wjg.14.2218] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i14/2218.htm |
| Number | Citing Articles |
| 1 |
Muhammad Ali, Samia Afzal, Asad Zia, Ahmed Hassan, Ali Talha Khalil, Muhammad Ovais, Zabta Khan Shinwari, Muhammad Idrees. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges. Medicine 2016; 95(50): e5327 doi: 10.1097/MD.0000000000005327
|
| 2 |
Shirin Mirza, Amna Rehana Siddiqui, Saeed Hamid, Muhammad Umar, Shaheena Bashir. Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-71
|
| 3 |
Nathan Ford, Catherine Kirby, Kasha Singh, Edward J Mills, Graham Cooke, Adeeba Kamarulzaman, Philipp duCros. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bulletin of the World Health Organization 2012; 90(7): 540 doi: 10.2471/BLT.11.097147
|
| 4 |
Saira Munir, Sana Saleem, Muhammad Idrees, Aaliyah Tariq, Sadia Butt, Bisma Rauff, Abrar Hussain, Sadaf Badar, Mahrukh Naudhani, Zareen Fatima, Muhmmad Ali, Liaqat Ali, Madiha Akram, Mahwish Aftab, Bushra Khubaib, Zunaira Awan. Hepatitis C Treatment: current and future perspectives. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-296
|
| 5 |
Muhammad Amir, Attiya Sabeen Rahman, Qaiser Jamal, Muhammad Asadullah Siddiqui. End treatment response and sustained viral response in hepatitis C virus genotype 3 among Pakistani population. Annals of Saudi Medicine 2013; 33(6): 555 doi: 10.5144/0256-4947.2013.555
|
| 6 |
Sadia Ashraf, Aftab Ahmad. Viral hepatitis in Pakistan: challenges and priorities. Asian Pacific Journal of Tropical Biomedicine 2015; 5(3): 190 doi: 10.1016/S2221-1691(15)30004-6
|
| 7 |
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall. Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?. World Journal of Gastroenterology 2008; 14(43): 6627-6631 doi: 10.3748/wjg.14.6627
|
| 8 |
Alessandro Federico, Mario Masarone, Marco Romano, Marcello Dallio, Valerio Rosato, Marcello Persico. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. Hepatitis Monthly 2015; 15(6) doi: 10.5812/hepatmon.15(6)2015.18640
|
| 9 |
Muhammad Ali, Irshad Ur Rehman, Muhammad Idrees. Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan. Virus Genes 2014; 48(3): 543 doi: 10.1007/s11262-014-1047-y
|
| 10 |
Atika Mansoor, Lubna Ali, Noor-ul Sabah, Asraf Hussain Hashmi, Mohammad Haroon Khan, Syed Ali Raza Kazmi, Nafees Ahmad, Saima Siddiqi, Khalid Mehmood Khan. Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-352
|
| 11 |
Madiha Akram, Muhammad Idrees, Shamail Zafar, Abrar Hussain, Sadia Butt, Samia Afzal, Irshad-ur Rehman, Ali Liaqat, Sana Saleem, Muhammad Ali, Azeem Butt. Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-234
|
| 12 |
S. K. Tohra, S. Taneja, S. Ghosh, B. K. Sharma, A. Duseja, R. K. Dhiman, A. Das, Y. K. Chawla. Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C. Digestive Diseases and Sciences 2011; 56(8): 2449 doi: 10.1007/s10620-011-1770-3
|
| 13 |
Sadia Butt, Muhammad Idrees, Haji Akbar, Irshad ur Rehman, Zunaira Awan, Samia Afzal, Abrar Hussain, Muhammad Shahid, Sobia Manzoor, Shazia Rafique. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infection, Genetics and Evolution 2010; 10(5): 595 doi: 10.1016/j.meegid.2010.04.012
|